Fonadelpar (SJP-0035; NPS-005) is a novel, potent, and selective PPAR δ (peroxisome proliferator activated receptor δ) agonist with the potential for the treatment of corneal disorders and for the research of neuroparalytic keratopathy.

纯度：≥98%

CAS：515138-06-4